Business Wire

Green Street Acquires IJGlobal, Leading Provider of Global Infrastructure Data, News and Events

Share

--Green Street Continues to Grow, Expanding Its Global Product Suite with Comprehensive and Granular Property-Level Data, News and Events in Infrastructure--

Green Street, the preeminent provider of commercial real estate intelligence and analytics in the U.S., Canada, and Europe, has acquired IJGlobal, part of the Delinian Group – leading provider of data, news, and events covering all aspects of the international infrastructure and energy finance industry. IJGlobal is Green Street’s fifth acquisition since 2020, and it follows the May 2024 acquisition of Locatus – a Netherlands based provider of independently sourced retail data and analytics in the Benelux region.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905220824/en/

Green Street, the leading provider of Commercial Real Estate intelligence, acquires IJGlobal, a comprehensive infrastructure company that includes a data platform, global news, and industry leading events/awards. (Graphic: Business Wire)

“IJGlobal is committed to being the market’s most comprehensive source of infrastructure intelligence with a global presence across North America, South America, Asia, Africa, Europe, and Australia, and its great talent and reputation for providing top-quality objective insights make a strong fit for Green Street. IJGlobal’s deep coverage of infrastructure accelerates our commitment to expanding property-level data and analytics across sectors and geographies and dramatically strengthens our increasing coverage of the infrastructure sector on a global basis,” said Jeffry Stuek Jr., Green Street’s Chief Executive Officer. “We are excited to integrate these capabilities to provide our clients with industry leading insight.”

For more than 17 years, IJGlobal has been delivering the market’s most comprehensive infrastructure intelligence through a database of 55,000+ transactions, 41,000+ assets, and 3,400+ funds. Their team of experts publishes more than 40 stories a day to inform financial structure, policy, pricing, and key market players, helping customers manage risk and identify leads. They also track and celebrate key infrastructure and energy industry achievements through a multitude of annual Events and Awards that connect the market and accelerate deals. IJGlobal services a wide range of customer segments including financial advisers and lenders, legal advisers, Development Finance Institutions (DFIs), institutional investors, project sponsors, and infrastructure funds, among others.

Commenting on the sale, Andrew Pinder, Chief Executive Officer of Delinian, said, “In line with our continued strategy of ‘invest, grow and divest’ for each of our portfolio companies, we are delighted that Green Street represents such a great fit for IJGlobal. It offers the business an exciting opportunity to further expand its depth and reach of infrastructure insights, data and events, with access to resources and expertise within a broader property-level data and analytics ecosystem. We wish the IJGlobal team every success as they now transition to Green Street.”

For more information, visit the IJGlobal website or Green Street website.

About Green Street

Green Street is the preeminent provider of actionable commercial real estate research, news, data, analytics, and advisory services in the U.S., Canada, and Europe. For nearly 40 years, Green Street has delivered unparalleled intelligence and trusted data on the public and private real estate markets, helping investors, banks, lenders, and other industry participants optimize investment and strategic decisions. The firm delivers exclusive market information, conclusion-driven insights, and predictive analytics through a SaaS platform. To learn more, please visit https://www.greenstreet.com.

About IJGlobal

IJGlobal is a single source of data, intelligence and analysis covering all aspects of the international infrastructure and energy finance industry. IJGlobal delivers news, transaction and investor/fund data, and events for global infrastructure to market participants worldwide, and through a comprehensive database that encompasses all infrastructure transaction participants, exclusive daily news, live League Table rankings, and more. IJGlobal is headquartered in London and was founded in 1997. For more information, please visit https://hub.ijglobal.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240905220824/en/

Contacts

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vonage Network APIs Pave the Way for Freenow by Lyft to Advance Urban Mobility Innovation22.1.2026 08:00:00 CET | Press release

Freenow adopts Vonage APIs to access network capabilities, strengthening fraud prevention through faster, verified connections with drivers for millions of riders Vonage, a part of Ericsson, and Freenow by Lyft, a leading taxi and multi-mobility app in Europe, have expanded their partnership with the launch of Vonage Silent Authentication API for customers based in the U.S. Vonage Network APIs enable Freenow by Lyft to tap into real-time network data and insights, helping prevent fraud through seamless user verification, ensuring reliable, efficient, and secure interactions for its customers and drivers. Network intelligence is becoming a critical layer of defense in the transportation space as fraud threats become more sophisticated and targeted. Enterprises worldwide lost 7.7% of their annual revenue on average due to fraud over the past year, representing an estimated $534 billion in losses.¹ With scam/authorization fraud, synthetic identity fraud, and account takeover as the leadin

Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe22.1.2026 07:30:00 CET | Press release

Daiichi Sankyo (TSE:4568) has appointed Veronika Rozehnal, Ph.D., to succeed Jürgen Müller, Ph.D., as the Head of the Translational Research Center Europe. Dr. Jürgen Müller will retire after nearly 30 years of research work at Daiichi Sankyo. Under his leadership, the Translational Research Center Europe, previously called the Tissue and Cell Research Center Munich, has grown from three to 40 researchers since it was founded in 1997 and has become an internationally recognized institution that plays a strategic role in the global innovation process of Daiichi Sankyo. Dr. Veronika Rozehnal joined Daiichi Sankyo in 2009 and has held various positions at the Translational Research Center Europe in addition to spending three years at the Daiichi Sankyo R&D Center in Tokyo. Dr. Rozehnal graduated from Ernst-Moritz-Arndt University of Greifswald, Germany with a Ph.D. degree in Clinical Pharmacology. “Jürgen Müller has made significant scientific contributions that have helped Daiichi Sankyo

Azafaros Announces Key Scientific Oral and Poster Presentations on Nizubaglustat Accepted for WORLDSymposium™ 202622.1.2026 07:00:00 CET | Press release

Five presentations will showcase nizubaglustat’s therapeutic potential in Lysosomal Storage Disorders. Nizubaglustat is currently being tested in two global Phase 3 studies for Niemann-Pick type C disease and GM1/GM2 gangliosidoses which are currently recruiting. Azafaros will host a satellite symposium on nizubaglustat on Day 2 of the symposium discussing the Phase 3 studies. WORLDSymposium™ 2026 takes place from February 2 to 6 in San Diego, California. Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that its lead asset, nizubaglustat, will feature in five scientific presentations accepted at the WORLDSymposium™ 2026, the leading global conference on lysosomal diseases, taking place in San Diego, California, USA between February 2-6. The company’s conference activities include: Oral Presentations (including Poster numbers 134 and 29-C) Long-term data from a Phase II study wit

I Squared Announces Launch of Radiant Energy Solutions22.1.2026 07:00:00 CET | Press release

I Squared Capital (“I Squared”), a leading global infrastructure investment manager, announced today the launch of Radiant Energy Solutions (“Radiant”), an investment from I Squared’s Middle East infrastructure strategy, which is focused on targeting transformational, mid-market investments in the region. Reflecting I Squared’s platform-building approach of starting with a core initial investment and scaling over time to build market-leading businesses, Radiant marks the firm’s entry into the Middle East distributed renewables market, providing decarbonization solutions to commercial and industrial customers. The investment for Radiant is the acquisition of FAS Renewables and its 100% owned subsidiary Zahra Energy, a Saudi Arabia–based distributed solar company with a secured and advanced portfolio of over 100MWp of distributed solar projects with established customers and long-term contracted solar power purchase agreements. These include Cenomi Centers, an owner, operator, and develo

IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio22.1.2026 07:00:00 CET | Press release

At IMCAS 2026, Galderma will present findings supporting Sculptra’s® regenerative properties and benefits on the body, including improving cellulite appearance, firmness, lift, projection, and contouring following its European Union (EU) Medical Device Regulation (MDR) certification, expanding its use to four body areas1-7 Multiple studies will reinforce the safety and efficacy of Galderma’s hyaluronic acid (HA) treatments range, including post-marketing data on Restylane® Shaype™ in shaping the chin, Restylane Lyft™ in improving jawline definition, Restylane Skinboosters™ in smoothing fine lines and wrinkles in the décolletage and Restylane Volyme™ in correcting hollowing of the temples8-11 New data on the innovative neuromodulator Relfydess™ (RelabotulinumtoxinA) will reinforce its rapid onset as early as Day 1 and sustained efficacy through six months for frown lines and crow’s feet12 As a leader in injectable aesthetic innovation, Galderma will showcase its superior science and edu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye